Rockwell Medical (RMTI) Notes Payables (2019 - 2026)

Rockwell Medical (RMTI) reported Notes Payables of $66000.0 for Q1 2026, down 1.49% on a YoY basis from $67000.0 in Q1 2025, and down 75.0% quarter-over-quarter from $264000.0 in Q4 2025.

Rockwell Medical (RMTI) Notes Payables (2019 - 2026) Analysis & Trends

Rockwell Medical has reported Notes Payables for 8 years, with the latest figure at $66000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Notes Payables fell 1.49% year-over-year to $66000.0; the trailing twelve-month figure through Mar 2026 stood at $66000.0 (down 1.49% YoY), and the FY2025 full-year result was $264000.0, down 1.49% from the prior year.
  • Notes Payables for Q1 2026 stood at $66000.0, down from $264000.0 in the prior quarter.
  • The five-year high for Notes Payables was $1.5 million in Q2 2022, with the low at $66000.0 in Q1 2026.
  • Historically, Notes Payables has averaged $529214.3 across 5 years, with a median of $478500.0 in 2023.
  • Annual changes were most pronounced in 2022 — Notes Payables grew 15.1% — and 2023, when it plunged 51.49%.
  • Rockwell Medical's Notes Payables stood at $503000.0 in 2022, then sank by 51.49% to $244000.0 in 2023, then advanced by 9.84% to $268000.0 in 2024, then dropped by 1.49% to $264000.0 in 2025, then slumped by 75.0% to $66000.0 in 2026.
  • The last three Notes Payables figures came in at $66000.0 (Q1 2026), $264000.0 (Q4 2025), and $462000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Rockwell Medical 26.01 Mn 2.12 Mn 2.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66,000.00
Dec 31, 2025 264,000.00
Sep 30, 2025 462,000.00
Jun 30, 2025 660,000.00
Mar 31, 2025 67,000.00
Dec 31, 2024 268,000.00
Sep 30, 2024 469,000.00
Jun 30, 2024 670,000.00
Dec 31, 2023 244,000.00
Sep 30, 2023 488,000.00
Jun 30, 2023 733,000.00
Dec 31, 2022 503,000.00
Sep 30, 2022 1.01 Mn
Jun 30, 2022 1.51 Mn
Dec 31, 2021 437,000.00
Sep 30, 2021 1.31 Mn
Mar 31, 2020 190,855.00
Dec 31, 2019 763,000.00
Sep 30, 2019 1.15 Mn
Jun 30, 2019 1.90 Mn